As of Oct 2, 2026: fair value of NEWTI $75.30, price $25.10, upside +200.0%, quality 44 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
NEWTI (NEWTI) currently trades at $25.10, while our model-based Fair Value estimate is $75.30, implying the stock looks roughly 66.7% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $120.84 per share, and 23 of the 26 models we run sit above the $25.10 price.
Bear case: the Asset-Based group reads lowest at $15.69, and 3 of the 26 models stay below the price. Evidence for this calculation is low.
Scenario range: $52.71 (bear) to $97.89 (bull), the price of $25.10 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 44/100 (below-average quality), in the Other sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
NEWTI reported revenue of $322M in FY2025 versus $168M in FY2021, a compound +17.6%/yr. Reported net income was $60.5M in FY2025, compounding −7.9%/yr from FY2021.
Key figures
Market cap $780M · Net margin 18.8% · Return on assets (EBIT) 4.7% · Free cash flow $55.9M · Net debt $539M.
What moves the price
For context, the median of 10 Other peers we cover trades at 28% fair-value upside, at 200%, NEWTI screens cheaper than that median.
Fair Value models
Bear $52.71Fair Value $75.30Bull $97.89
Price $25.10 · Upside +200.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.90/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+1.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+34.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+28.3%
Start year 2020 (pandemic). Over 10 years: +28.6% a year
Revenue growth 26 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.5%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+2.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year+2.7%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.2.7% vs 2.4%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.35% → 43%
Start year 2020 (pandemic)
⚠ Revenue per share shrinking 3.2%/yr over ~10Y (margin trend unclear) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−1.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −3.7% a year for the price.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "NEWTI Fair Value". https://www.fairvalue-calculator.com/stock/NEWTI
Frequently asked questions
Is NEWTI overvalued or undervalued?
As of Oct 4, 2026, our model estimates a fair value of $75.30 versus a price of $25.10, about +200% upside (undervalued).
What is the fair value of NEWTI?
Our model-based fair value for NEWTI is $75.30 (as of Oct 4, 2026), built from audited fundamentals. The current price: $25.10.
What is the quality score of NEWTI?
NEWTI has a Quality Score of 44/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for NEWTI?
Our model-based price target is the fair value of $75.30 (as of Oct 4, 2026) from 26 valuation models. Cautious scenario $52.71, optimistic scenario $97.89. It is a calculation from audited fundamentals, not an analyst target.
What is the NEWTI stock forecast for 2026?
Our models put fair value at $75.30, about +200% upside versus a price of $25.10 (undervalued). Cautious scenario $52.71, optimistic scenario $97.89. The calculation is refreshed regularly with new filings.
What growth is priced into NEWTI?
For today's price to be fair in a discounted-cash-flow model, NEWTI would have to grow free cash flow by -1.4 % per year for five years (discount rate 11.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +28.3 % per year. As of Oct 4, 2026.
What discount rate (WACC) does the fair value of NEWTI use?
Our models discount NEWTI at 11.2 %: a base by market capitalisation (small), country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For NEWTI that is -1.4 % per year a year over ten years, using the same discount rate (11.2 %) and the same formula as our fair value.
How much growth has NEWTI delivered so far?
Over the past 5 years revenue at NEWTI grew +28.3 % a year. The price currently implies -1.4 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
What is the free cash flow yield of NEWTI?
The free-cash-flow yield on the price is 7.16 %: that much free cash flow NEWTI produces per unit of market value. When it exceeds the discount rate of our models (11.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of NEWTI?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For NEWTI it is $75.30 per share (as of Oct 4, 2026), against a price of $25.10. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is NEWTI stock overvalued or undervalued in 2026?
As of Oct 4, 2026, NEWTI trades below its calculated fair value: price $25.10, fair value $75.30, a gap of about +200% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NEWTI?
No. The price is what the market pays today ($25.10); the fair value is what the company's own numbers justify ($75.30). For NEWTI the two are $50.20 per share apart. That gap is exactly why we show both numbers side by side.
How much is NEWTI worth?
The market values NEWTI at about $780M (market capitalisation, as of Oct 4, 2026). Per share that is $25.10; our models calculate a fair value of $75.30 per share.
What do the bullish and bearish scenarios say about NEWTI?
Our models span a range for NEWTI: cautious scenario $52.71, base $75.30, optimistic $97.89 per share (as of Oct 4, 2026, price $25.10). The range comes from different growth and margin assumptions, not from analyst opinions.
Which stocks are comparable to NEWTI?
From the same area (Other) we also value JSM, 542772, 532468, 590024, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is NEWTI stock attractive at the current price?
The data as of Oct 4, 2026: price $25.10, calculated fair value $75.30 (+200%), Quality Score 44/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NEWTI calculated?
We run NEWTI through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $75.30, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.9 % above its aggregate fair value. NEWTI currently trades 67 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of NEWTI?
The closing price on Oct 2, 2026 was $25.10. Our model-based fair value is $75.30, about +200% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with NEWTI right now?
The large discount to fair value meets weak quality (44/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($52.71). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range ($52.71 to $97.89) leaves room in how you read the outcome.
Key figures of NEWTI
How large is the market capitalisation of NEWTI?
The market capitalisation of NEWTI is $780M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the net margin of NEWTI?
The net margin of NEWTI is 18.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of NEWTI?
On an EBIT basis the return on assets of NEWTI is 4.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much net debt does NEWTI carry?
The net debt of NEWTI is $539M (fiscal year 2025, ≈ 9.6 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch NEWTI in the live analysis
One click puts NEWTI on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Oct 4, 2026